Bristol-Myers Squibb Company Common Stock (BMY)
Healthcare › Pharmaceutical Preparations
Price History
Feb 9, 2026 — Aug 7, 2026Investment Snapshot
- Trading 67% above Graham Number — above intrinsic value estimate
- Piotroski F-Score 7/9 — financially strong with improving fundamentals
- Strong ROE of 42.6% with 19.4% net margin
- High dividend yield of 4.4%
Bristol-Myers Squibb Company Common Stock (BMY) is a Healthcare company operating in Pharmaceutical Preparations, listed on the NYSE , with a market capitalisation of $115.4 billion . Key value metrics: P/E ratio 12.1, P/B ratio 5.17, Piotroski F-Score 7 out of 9 (strong financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
Bristol-Myers Squibb Company Common Stock — Fundamental Analysis Summary
Bristol-Myers Squibb Company Common Stock (BMY) is currently trading 67% above its Graham Number of $33.82, suggesting the market price exceeds Benjamin Graham's intrinsic value estimate. The stock carries a reasonable trailing P/E ratio of 12.1x.
On financial health, BMY shows a strong Piotroski F-Score of 7/9, indicating improving fundamentals across profitability, leverage, and efficiency, and strong return on equity of 42.6% (sector average: -20.1%), and elevated leverage with a debt-to-equity ratio of 1.97.
StockPik's composite Value Score for BMY is 94/100 — placing it in undervalued territory. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
BMY shows revenue declining at 0% year-over-year, with earnings growing at 179%.
BMY pays a solid dividend yield of 4.4%.